Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
The family of Henrietta Lacks has filed a federal lawsuit in Maryland against Novartis AG (NYSE:NVS) and Viatris Inc (NASDAQ:VTRS), alleging the companies profited unlawfully from the use of her tissue cells, known as "HeLa" cells.
亨莉埃塔 · 拉克斯的家人在马里兰州对诺华制药（NYSE：NVS）和Viatris Inc（NASDAQ：VTRS）提起了联邦诉讼，指控这些公司非法从使用其组织细胞（称为“HeLa”细胞）中获利。
The Lacks estate claims these cells, which were taken without her knowledge in the 1950s, have been crucial to the companies' drug developments without any compensation or permission granted to her estate.
Lacks家族声称这些细胞是在20世纪50年代未经她知情便被取出，对这些公司的药物开发至关重要，但她的遗产未获得任何补偿或授权。
Ben Crump, the Lacks family attorney, emphasized the historical exploitation of Black individuals in medical research, highlighting Lacks' story as a stark example.
Lacks家族律师本·克朗普强调了黑人在医疗研究中的历史剥削，以拉克斯的故事为鲜明例证。
The lawsuit follows previous actions against Thermo Fisher Scientific Inc (NYSE:TMO), which has since been settled, and ongoing litigation against Ultragenyx Pharmaceutical Inc (NASDAQ:RARE).
此诉讼是在之前对热电费休尔科技公司（纽交所股票代码：TMO）的诉讼得到解决之后进行的，并针对Ultragenyx Pharmaceutical Inc（纳斯达克股票代码：RARE）的持续诉讼。
Henrietta Lacks's cells were taken from her cervix during cancer treatment in 1951 at a Baltimore hospital.
亨丽埃塔·拉克斯的细胞是在巴尔的摩医院进行癌症治疗期间从她的子宫颈中取出的。
Reuters noted that these HeLa cells were the first to survive and reproduce indefinitely in lab conditions. Lacks passed away from cervical cancer later that year at the age of 31.
路透社指出，这些HeLa细胞是首批在实验室条件下无限生长和繁殖的细胞。拉克斯当年因子宫颈癌去世，享年31岁。
The complaint details how Novartis allegedly used HeLa cells in the development of its herpes drug Famvir, cancer treatment Kymriah, and spinal muscular atrophy therapy Zolgensma.
起诉书详细说明了诺华公司（Novartis）涉嫌在疱疹药物Famvir、癌症治疗Kymriah和脊髓性肌肉萎缩症疗法Zolgensma的开发中使用HeLa细胞。
Viatris is accused of using these cells to test its herpes drug, Denavir, and depression treatment, Mylan-Mirtazapine.
Viatris被指控使用这些细胞测试其疱疹药物Denavir和抗抑郁症药物Mylan-Mirtazapine。
The Lacks family seeks profits from the commercialization of HeLa cells and a court order to prevent further use without permission.
Lacks家族寻求从HeLa细胞的商业化获得利润，并获得法院命令以防止未经许可进一步使用。
Price Action: At the last check on Tuesday, NVS stock was up 0.36% at $110.25, and VTRS stock was down 0.30% at $11.53.
股价行情：上次检查时，NVS股价上涨0.36％至110.25美元，VTRS股价下跌0.30％至11.53美元。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免责声明：本内容部分使用人工智能工具生成，并经Benzinga编辑审核发布。